Expected US Company Earnings on Tuesday, November 14th, 2023

Stock Information for Onconova Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Onconova Therapeutics Inc.

Class Action Filed Against UroGen Pharma Ltd. (URGN) - July 28, 2025 Deadline to Join - Contact The Gross Law Firm
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that UroGen Pharma Ltd. (URGN) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
URGN INVESTOR ALERT: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
URGN INVESTOR NEWS: UroGen Pharma Ltd. has been Sued for Securities Fraud - Contact BFA Law before July 28 Deadline (NASDAQ:URGN)
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages UroGen Pharma Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - URGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd. - URGN
Faruqi & Faruqi Reminds UroGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 28, 2025 - URGN

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.